 | | Cardiovascular Exchange Summit 2011 |
|  | | Extra-vascular inflammatory drive |
|
 | | Acute to Chronic inflammation |
|  | | Atherosclerosis: fat accumulation in macrophages |
|
|  | | Atheroma destabilisation |
|
 | | Atherothrombosis |
|  | | Inflammation and coagulation |
|
 | | Inflammatory markers and CV-risk |
|  | | LDL lowering in JUPITER |
|
 | | CRP lowering in JUPITER |
|  | | Treatment of CID |
|
 | | Treatment of CID lowers risk |
|  | | Even short-term MMF lowers plaque inflammation |
|
 | | Central role for macrophages |
|  | | Plaque inflammation: Value of PET scanning |
|
 | | FDG Uptake: Modulation by Therapy |
|  | | Local delivery of statins ? |
|
 | | [Statin]-rHDL slows atherosclerosis progression |
|  | | Liposomal vs systemic prednisolon |
|
 | | Experimental model |
|
|
|
|
|
|
 | | Dalcetrapib and Atherosclerosis/inflammation: Dal-Plaque study |
|  | | Change from Baseline in Average Carotid Total Vessel Area by MRI |
|
 | | PET-CT Data |
|  | | Liposomal prednisolon in atherosclerotic disease? |
|
 | | SILENCE (phase I) |
|
Deel deze pagina met collega's en vrienden: